Operating Segment |
12 Months Ended |
|---|---|
Jan. 31, 2026 | |
| Operating Segment | |
| Operating Segment | 17. Operating Segment
The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area. All of the Company’s long-lived assets are located in Canada. |